Drug-resistant HIV in South Africa: status and response
PUBLICATION YEAR: 2021
TITLE AUTHOR(S): S.Moyo, G.Hunt, A.Feizzadeh, K.Zuma, T.Rehle
KEYWORDS: ANTIRETROVIRAL THERAPY (ART), DRUG RESISTANCE, HIV/AIDS
DEPARTMENT: Public Health, Societies and Belonging (HSC)
Print: HSRC Library: shelf number 11954
HANDLE: 20.500.11910/15985
URI: http://hdl.handle.net/20.500.11910/15985
If you would like to obtain a copy of this Research Output, please contact Hanlie Baudin at researchoutputs@hsrc.ac.za.
Abstract
As with other antimicrobial agents, widespread use of life saving antiretroviral (ARV) drugs for the management of infection with HIV comes with the risk of the development of antimicrobial resistance. The risk of the development of HIV mutations with resistance to ARVs may be exacerbated by weaknesses in health services and by the loss of patients from the cascade of care. Drug-resistant HIV is associated with a higher risk of mortality, and high levels of drug-resistant HIV will impede progress towards attainment of the 95-95-95 UNAIDS targets and could potentially reverse the remarkable progress that has been made by the antiretroviral treatment (ART) programme to date. This policy brief presents findings on drug-resistant HIV in South Africa and suggests policy responses to this emerging issue.-
Related Research Outputs:
- HIV drug resistance profile in South Africa: findings and implications from the 2017 national HIV household survey
- HIV drug resistance among virally unsuppressed respondents in the 5th South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2017
- Maternal factors associated with infant neurodevelopment in HIV-exposed uninfected infants
- Potential impact and cost-effectiveness of condomless-sex-concentrated PrEP in KwaZulu-Natal accounting for drug resistance
- Adolescent human immunodeficiency virus self-management: associations with treatment adherence, viral suppression, sexual risk behaviours and health-related quality of life
- Lottery incentives have short-term impact on ART initiation among men: results from a randomized pilot study
- PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study
- Data driven HIV programming to maximise health benefits
- Towards achieving the 90-90-90 HIV targets: results from the South African 2017 national HIV survey
- Being ALHIV and staying alive: what do we know about adolescents living with HIV in South Africa?
- Universal test and treat not enough to end HIV epidemic
- How community ART delivery may improve HIV treatment outcomes: qualitative inquiry into mechanisms of effect in a randomized trial of community-based ART initiation, monitoring and re-supply (DO ART) in South Africa and Uganda
- Association between ART adherence and mental health: results from a national HIV sero-behavioural survey in South Africa
- Understanding factors influencing utilization of HIV prevention and treatment services among patients and providers in a heterogeneous setting: a qualitative study from South Africa
- Is there risk compensation among HIV infected youth and adults 15 years and older on antiretroviral treatment in South Africa?: findings from the 2017 national HIV prevalence, incidence, behaviour and communication survey
- Completion of the tuberculosis care cascade in a community-based HIV linkage linkage-to-care study in South Africa and Uganda
- Perspectives of healthcare professionals of the neuropsychiatric side effects associated with efavirenz and its management
- Achieving 90-90-90: a focus on sero-discordant couples
- The psychology of "cure": unique challenges to consent processes in HIV cure research in South Africa
- School connectedness as psychological resilience factor in children affected by HIV/AIDS